Recurrent focal segmental glomerulosclerosis in the renal allograft: Single center experience in the era of modern immunosuppression

Clinical Nephrology

Volumn 74, Issue 3, 2010, Pages 173-181

  Schachter, M E ^a   Monahan, M ^b   Radhakrishnan, J ^b   Crew, J ^b   Pollak, M ^c   Ratner, L ^b   Valeri, A M ^b   Stokes, M B ^b   Appel, G B ^b  

^a ST PAUL S HOSPITAL   (Canada)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Recurrent focal segmental glomerulosclerosis; Renal pathology including clinicopathologic correlations; Renal transplantation

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GENETIC ANALYSIS; GRAFT RECIPIENT; HEALTH CENTER; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; PLASMAPHERESIS; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; ADOLESCENT; BIOPSY; CHILD; KIDNEY TRANSPLANTATION; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; RISK FACTOR; STATISTICAL MODEL;

ADOLESCENT; ADULT; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PLASMAPHERESIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 77957163842     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp74173     Document Type: Article

References (36)

1. Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Sem Nephrol. 2003; 23: 172-182.
2. Korbet SM, Genchi RM, Borok RZ, Schwartz MM. The racial prevalence of glomerular lesions in nephritic adults. Am J Kidney Dis. 1996; 27: 647-651.
3. Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976 - 1979 and 1995 - 1997. Am J Kidney Dis. 1997; 30: 621-631.
4. Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA Jr, Germain MJ. Changing incidence of glomerular diseases in adults. Am J Kidney Dis. 2000; 35: 878-883.
5. Swaminathan S, Leung N, Lager DJ, Melton LJ 3rd, Bergstralh EJ, Rohlinger A, Fervenza FC. Changing incidence of glomerular disease in Olmsted County, Minnesota: A 30-year renal biopsy study. Clin J Am Soc Nephrol. 2006; 1: 483-487.
6. Kitiyakara C, Eggers, P, Kopp JB. Twenty-one year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis. 2004; 44: 815.
7. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002; 347: 103-109.
8. Senggutuvan P, Cameron JS, Hartley RB, Rigden S, Chantler C, Haycock G, Williams DG, Ogg C, Koffman G. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol. 1990; 4: 21.
9. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med. 1992; 92: 375.
10. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol. 1992; 2 (Suppl): 258.
11. Newstead C. Recurrent disease in renal transplants. Nephrol Dial Transplant. 2003; 18 (Suppl): 68-74.
12. Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JC. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int. 2006; 69: 920-926.
13. Stephanian E, Matas AJ, Mauer SM, Chavers B, Nevins T, Kashtan C, Sutherland DE, Gores P, Najarian JS. Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis. Transplantation. 1992; 53: 755.
14. Hinkes BG. Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F. Arbeitsgemeinschaft für Paediatrische Nephrologie Study Group. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics. 2007; 119: 907-919.
15. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004; 43: 368-382.
16. Howie AJ, Pankhurst T, Sarioglu S, Turhan N, Adu D. Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int. 2005; 67: 987-1001.
17. Ponticelli C, Rizzoni G, Edofonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int. 1993; 43: 1377-1384.
18. Cattran DC, Appel GA, Hebert LA, Hunsicker LG, Pohl MA, Hoy W, Maxwell DR, Kunis CL. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int. 1999; 56: 2220-2226.
19. Letavernier E, Bruneval P, Mandet C, Van Huyen JP, Péraldi MN, Helal I, Noël LH, Legendre C. High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol. 2007; 2: 326-333.
20. Abbott KC, Sawyers ES, Oliver JD, Ko CW, Kirk AD, Welch PG, Peters TG, Agodoa LY. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis. 2001; 37: 366-373.
21. Swaminathan S, Lager DJ, Qian X, Stegall MD, Larson TS, Griffin MD. Collapsing and non-collapsing focal segmental glomeruloslcerosis in kidney transplants. Nephrol Dial Transplant. 2006; 21: 2607-2614.
22. Ijpelaar DHT, Farris AB, Goemaere N, Amann K, Goldschmeding R, Nguyen TQ, Farkash E, van den Heuvel MC, de Heer E, Bruijn JA, Colvin RB, Bajema IM. Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol. 2008; 19: 2219-2224.
23. D'Agati VD. The spectrum of focal segmental glomerulosclerosis: new insights. Curr Opin Nephrol Hypertens. 2008; 17: 271-281.
24. Kestila M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K. Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell. 1998; 1: 575-582.
25. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nature Genet. 2000; 24: 349-354.
26. Sharma M, Sharma R, Reddy SR, McCarthy ET, Savin VJ. Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation. 2002; 73: 366-372.
27. Ohta T, Kawaguchi H, Hattori M, Komatsu Y, Akioka Y, Nagata M, Shiraga H, Ito K, Takahashi K, Ishikawa N, Tanabe K, Yamaguchi Y, Ota K. Effect of pre- and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation. 2001; 71: 628-633.
28. Savin V, Sharma M, McArthy ET et al. Cardiotrophin like Cytokine-1: Candidate for the Focal Glomerular Sclerosis Permeability Factor. American Society of Nephrology, Annual Meeting, Philadelphia. Free Communication: Glomerular Disorders: New Insights into Pathophysiology, Treatment, and Outcomes. 2008.
29. Sharma M, Sharma R, McCarthy ET, Savin VJ. The focal segmental glomerulosclerosis permeability factor: Biochemical characteristics and biological effects. Exp Biol Med (Maywood). 2004; 229: 85-98.
30. Gohh RY, Yango AF, Morrissey PE, Monaco AP, Gautam A, Sharma M, McCarthy ET, Savin VJ. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant. 2005; 5: 2907-2912.
31. Dall'Amico R,Ghiggeri GM, Carraro M. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kid Dis. 1999; 34: 1048-1055.
32. Deegens JKJ, Andresdotter MB, Croockewit S et al. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant. Transpl Int. 2004; 17:151-157.
33. Valdivia P, Gonzales RF, Gentil MA, Wetzels JF. Plasmapheresis for the prophylaxis and treatment of recurrent focal segmental glomerulosclerosis following renal transplant. Transplant Proc. 2005; 37: 1473-1474.
34. Schwimmer J, Valeri A, Markowitz G, Appel GB. Collapsing Focal Sclerosis in Focal Sclerosis. In: Kopp J (ed). Seminars in Nephrology. 2003; 23: 209-218.
35. Nayagam LS, Ganguli L, Rathi M, Kohli HS, Gupta KL, Joshi K, Sakhuja V, Vivekanand J. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study. Nephrol Dial Transplant. 2008; 23: 1926-1930.
36. Doi T, Masaki T, Shiraki N, Kawai T, Yorioka N. Oral mizoribine pulse therapy for steroid-dependent focal segmental glomerulosclerosis. Clin Nephrol. 2008; 69: 433-435.